Ticagrelor-Related Severe Dyspnoea: Mechanisms, Characteristic Features, Differential Diagnosis and Treatment.
Alicja KrakowiakJakub KuletaIwona PlechMaciej ZarębińskiMalgorzata WojciechowskaDominik WretowskiAgnieszka Cudnoch-JędrzejewskaPublished in: Clinical medicine insights. Case reports (2020)
With a growing number of patients on ticagrelor therapy after stent implantation, we observe many cases of side effects of the drug, mostly dyspnoea and bradycardia. In our article we present 2 patients, in which the symptoms were particularly severe. Then we describe possible mechanisms of these complications, explain how to carry out differential diagnosis, discuss when to switch ticagrelor to other antiplatelet drug and finally we present the way to deal with the symptoms.